Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Covidien Updates On Voluntary Recall Of BIS Bilateral Sensors - Quick Facts

RELATED NEWS
Trade COV now with 

Covidien Plc (COV: Quote) in its update on voluntary recall of BIS Bilateral Sensors said to date, there have been no reports of patient injury related to the recalled products.

On November 8, 2011, the company initiated a voluntary recall of certain lots of its BIS Bilateral Sensors, due to a modification which inadvertently reversed the reference and left eye electrode. Covidien noted that this modification could potentially cause a change in the performance of BIS monitoring systems when these sensors are used, resulting in the inaccurate calculation and presentation of processed EEG information for Bispectral Index, or BIS, Density Spectral Array and Asymmetry values.

Click here to receive FREE breaking news email alerts for Covidien Plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Amazon.com, Inc. said Thursday that its second quarter loss widened from last year, as operating expenses outpaced revenue growth amid heavy spending on new technology and contents. The company's quarterly loss per share was also wider than what analysts expected, but is quarterly sales came in line with analysts' forecast. The company also forecast an operating loss for the current quarter. After failing to sustain an initial upward move, stocks showed a lack of direction throughout much of the trading day on Thursday. The major averages eventually closed nearly unchanged, turning in a mixed performance for the second straight day. New home sales in the U.S. showed a notable decrease in the month of June, according to a report released by the Commerce Department on Thursday, with the steep drop offsetting the jump seen in the previous month.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.